InsiderClue
← All stocks

Edwards Lifesciences

EW Mostly scheduled
CIK 0001099800 #170 in the set updated 17 Sep 2026
Bought (120 mo)
$1.82M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$818.66M
$7.12M on a plan · $775.64M straight out of an exercise
Sold at will
$35.90M
104 of 972 sales
Net
−$816.84M
−$34.08M against sales at will

By person

27 insiders · 981 transactions
7.9×

Mr. Zovighian holds 7.9 times base salary in stock. $9.43M of shares against $1.19M in salary for 2025.

Salary from the company's own proxy. The shares are what Mr. Zovighian last reported holding, valued at $87.51, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MUSSALLEM MICHAEL A
Director
—
$363.37M (296) scheduled
−$363.37M
4,042,863
0.7014%
$353.79M
+36.1%
BOBO DONALD E JR
CVP,Strategy/Corp Development
—
$118.50M (186) scheduled
−$118.50M
121,409
0.0211%
$10.62M
−40.0%
Ullem Scott B.
CVP, Chief Financial Officer
—
$75.91M (69) scheduled
−$75.91M
313,058
0.0543%
$27.40M
+20.8%
Wood Larry L
Global President TAVR & Surg
—
$75.28M (97) scheduled
−$75.28M
207,066
0.0359%
$18.12M
+22.1%
WANG HUIMIN
CVP, Japan & Intercontinental
—
$48.54M (81) scheduled
−$48.54M
99,381
0.0172%
$8.70M
−29.1%
Szyman Catherine M.
CVP, Critical Care
$1.07M (2)
$43.22M (84) scheduled
−$42.15M
81,287
0.0141%
$7.11M
+51.7%
Lemercier Jean-Luc M
CVP, EMEACLA and JAPAC
—
$22.66M (30) scheduled
−$22.66M
184,686
0.0320%
$16.16M
+38.7%
Zovighian Bernard J
CEO
$49.75K (1)
$14.21M (18) scheduled
−$14.16M
107,761
0.0187%
$9.43M
+252.5%
SELLERS ROBERT W.A.
SVP, Corporate Controller
—
$13.66M (18) scheduled
−$13.66M
37,490
0.0065%
$3.28M
−19.7%
Chopra Daveen
CVP, TMTT, Surgical & IHFM
—
$11.08M (24) scheduled
−$11.08M
43,926
0.0076%
$3.84M
+368.9%
Verguet Patrick B
CVP, Europe
—
$9.87M (11) scheduled
−$9.87M
129,137
0.0224%
$11.30M
0.0%
LINK WILLIAM J PHD
Director
—
$7.03M (8)
−$7.03M
16,071
0.0028%
$1.41M
−72.7%
GALLAHUE KIERAN
Director
$524.20K (2)
$3.84M (2) scheduled
−$3.32M
71,534
0.0124%
$6.26M
+131.0%
Marsh Martha H.
Director
—
$3.10M (1) scheduled
−$3.10M
31,880
0.0055%
$2.79M
+76.6%
STONE HEISZ LESLIE
Director
—
$2.92M (6) scheduled
−$2.92M
34,199
0.0059%
$2.99M
+166.2%
Lippis Daniel J.
CVP, TAVR
—
$1.93M (25) scheduled
−$1.93M
40,034
0.0069%
$3.50M
+116.4%
Markowitz Wayne
CVP, JAPAC
—
$1.11M (7) scheduled
−$1.11M
19,371
0.0034%
$1.70M
+8,591%
VON SCHACK WESLEY W
Director
—
$968.25K (4)
−$968.25K
9,737
0.0017%
$852.08K
−7.8%
VALERIANI NICHOLAS J
Director
$168.35K (1)
$698.75K (1) scheduled
−$530.41K
84,423
0.0146%
$7.39M
+140.0%
LORANGER STEVEN R
Director
—
$438.58K (1) scheduled
−$438.58K
8,997
0.0016%
$787.33K
—
Bruls Annette
CVP, EMEACLA
—
$237.91K (1)
−$237.91K
17,984
0.0031%
$1.57M
+122.6%
Dahl Andrew M.
SVP, Corporate Controller
—
$98.39K (2)
−$98.39K
14,615
0.0025%
$1.28M
+493.4%
Mistras Theodora
CVP, Chief Financial Officer
—
—
—
99,920
0.0173%
$8.74M
—
LAVIOLETTE PAUL A
Director
—
—
—
17,552
0.0030%
$1.54M
—
Davis Leslie C.
Director
—
—
—
9,834
0.0017%
$860.57K
—
Feinberg David T
Director
—
—
—
9,087
0.0016%
$795.20K
—
Sequeira Ramona
Director
—
—
—
6,779
0.0012%
$593.23K
—

Individual transactions

212
Insider
Date
Role
Action
Shares
Price
Amount
Lippis Daniel J.
11 Sep 2026
CVP, TAVR
Sold after exercise
619
$87.51
$54.17K
Chopra Daveen
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
30,646
$90.99
$2.79M
Chopra Daveen
26 Aug 2026
CVP, TMTT, Surgical & IHFM
Sold after exercise
1,154
$91.76
$105.89K
Lippis Daniel J.
11 Aug 2026
CVP, TAVR
Sold after exercise
619
$92.03
$56.97K
Markowitz Wayne
28 Jul 2026
CVP, JAPAC
Sold after exercise
9,628
$85.06
$818.96K
Lippis Daniel J.
10 Jul 2026
CVP, TAVR
Sold after exercise
619
$91.70
$56.76K
Lippis Daniel J.
30 Jun 2026
CVP, TAVR
Sold after exercise
619
$91.40
$56.58K
Lippis Daniel J.
18 May 2026
CVP, TAVR
Sold after exercise
620
$81.14
$50.31K
Lippis Daniel J.
4 May 2026
CVP, TAVR
Sold after exercise
1,019
$83.98
$85.58K
Lippis Daniel J.
1 May 2026
CVP, TAVR
Sold after exercise
1,000
$82.99
$82.99K
Lippis Daniel J.
1 May 2026
CVP, TAVR
Sold after exercise
19
$83.99
$1.60K
Ullem Scott B.
9 Apr 2026
CVP, Chief Financial Officer
Sold after exercise
8,324
$79.79
$664.14K
Ullem Scott B.
9 Apr 2026
CVP, Chief Financial Officer
Sold after exercise
4,676
$80.50
$376.40K
Lippis Daniel J.
6 Apr 2026
CVP, TAVR
Sold after exercise
1,019
$80.98
$82.52K
BOBO DONALD E JR
2 Apr 2026
CVP,Strategy/Corp Development
Sold after exercise
18,004
$80.05
$1.44M
BOBO DONALD E JR
2 Apr 2026
CVP,Strategy/Corp Development
Sold after exercise
4,676
$80.59
$376.85K
Lippis Daniel J.
11 Mar 2026
CVP, TAVR
Sold after exercise
1,019
$85.38
$87.00K
Ullem Scott B.
11 Mar 2026
CVP, Chief Financial Officer
Sold after exercise
7,901
$85.21
$673.23K
Ullem Scott B.
11 Mar 2026
CVP, Chief Financial Officer
Sold after exercise
5,099
$84.46
$430.67K
BOBO DONALD E JR
2 Mar 2026
CVP,Strategy/Corp Development
Sold after exercise
11,340
$85.93
$974.43K
Zovighian Bernard J
12 Feb 2026
CEO
Sold after exercise
19,898
$76.61
$1.52M
Zovighian Bernard J
12 Feb 2026
CEO
Sold after exercise
2,532
$77.13
$195.29K
Lippis Daniel J.
9 Jan 2026
CVP, TAVR
Sold after exercise
1,019
$85.70
$87.33K
BOBO DONALD E JR
6 Jan 2026
CVP,Strategy/Corp Development
Sold after exercise
8,708
$85.98
$748.71K
BOBO DONALD E JR
6 Jan 2026
CVP,Strategy/Corp Development
Sold after exercise
2,632
$84.62
$222.72K
Lippis Daniel J.
12 Dec 2025
CVP, JAPAC
Sold after exercise
1,019
$84.03
$85.63K
BOBO DONALD E JR
10 Dec 2025
CVP,Strategy/Corp Development
Sold after exercise
11,340
$83.83
$950.58K
Ullem Scott B.
9 Dec 2025
CVP, Chief Financial Officer
Sold after exercise
7,700
$84.47
$650.41K
Zovighian Bernard J
8 Dec 2025
CEO
Sold after exercise
21,487
$85.21
$1.83M
Lippis Daniel J.
10 Nov 2025
CVP, JAPAC
Sold after exercise
1,020
$82.55
$84.20K
Ullem Scott B.
10 Nov 2025
CVP, Chief Financial Officer
Sold after exercise
10,026
$83.02
$832.36K
Ullem Scott B.
10 Nov 2025
CVP, Chief Financial Officer
Sold after exercise
2,974
$83.30
$247.73K
Wood Larry L
18 Aug 2025
Global President TAVR & Surg
Sold after exercise
8,950
$78.06
$698.68K
Wood Larry L
16 Jun 2025
Global President TAVR & Surg
Sold after exercise
8,950
$75.23
$673.27K
Ullem Scott B.
9 May 2025
CVP, Chief Financial Officer
Sold after exercise
11,250
$74.40
$837.03K
Lippis Daniel J.
9 May 2025
CVP, JAPAC
Sold after exercise
330
$74.42
$24.56K
Zovighian Bernard J
5 May 2025
CEO
Sold after exercise
5,980
$74.91
$447.98K
BOBO DONALD E JR
14 Apr 2025
CVP,Strategy/Corp Development
Sold after exercise
9,500
$69.81
$663.20K
Lippis Daniel J.
8 Apr 2025
CVP, JAPAC
Sold after exercise
300
$70.61
$21.18K
Ullem Scott B.
26 Mar 2025
CVP, Chief Financial Officer
Sold after exercise
11,250
$70.87
$797.27K
BOBO DONALD E JR
13 Mar 2025
CVP,Strategy/Corp Development
Sold after exercise
9,500
$67.96
$645.62K
Lippis Daniel J.
10 Mar 2025
CVP, JAPAC
Sold after exercise
400
$69.48
$27.79K
Zovighian Bernard J
10 Mar 2025
CEO
Sold after exercise
6,164
$69.51
$428.45K
Ullem Scott B.
28 Feb 2025
CVP, Chief Financial Officer
Sold after exercise
7,760
$70.52
$547.20K
Ullem Scott B.
28 Feb 2025
CVP, Chief Financial Officer
Sold after exercise
3,490
$71.38
$249.12K
LORANGER STEVEN R
14 Feb 2025
Director
Sold after exercise
5,739
$76.42
$438.58K
STONE HEISZ LESLIE
13 Feb 2025
Director
Sold after exercise
5,739
$75.86
$435.37K
Lippis Daniel J.
13 Feb 2025
CVP, JAPAC
Sold after exercise
500
$76.34
$38.17K
BOBO DONALD E JR
13 Feb 2025
CVP,Strategy/Corp Development
Sold after exercise
6,400
$75.74
$484.74K
BOBO DONALD E JR
13 Feb 2025
CVP,Strategy/Corp Development
Sold after exercise
100
$76.26
$7.63K
Ullem Scott B.
13 Feb 2025
CVP, Chief Financial Officer
Sold after exercise
11,250
$75.76
$852.27K
BOBO DONALD E JR
16 Jan 2025
CVP,Strategy/Corp Development
Sold after exercise
5,000
$68.75
$343.74K
Lippis Daniel J.
16 Jan 2025
CVP, JAPAC
Sold after exercise
500
$68.76
$34.38K
Lippis Daniel J.
16 Dec 2024
CVP, JAPAC
Sold after exercise
2,500
$74.08
$185.20K
BOBO DONALD E JR
9 Dec 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$71.75
$358.75K
Ullem Scott B.
9 Dec 2024
CVP, Chief Financial Officer
Sold after exercise
11,250
$71.68
$806.41K
BOBO DONALD E JR
13 Nov 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$65.57
$327.84K
BOBO DONALD E JR
15 Oct 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$69.51
$347.53K
BOBO DONALD E JR
11 Sep 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$66.77
$333.83K
BOBO DONALD E JR
14 Aug 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$66.08
$330.42K
Lippis Daniel J.
11 Jul 2024
CVP, JAPAC
Sold after exercise
500
$94.18
$47.09K
BOBO DONALD E JR
10 Jul 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$93.29
$466.47K
Ullem Scott B.
20 Jun 2024
CVP, Chief Financial Officer
Sold after exercise
5,225
$87.47
$457.01K
Ullem Scott B.
20 Jun 2024
CVP, Chief Financial Officer
Sold after exercise
400
$88.11
$35.25K
Lippis Daniel J.
20 Jun 2024
CVP, JAPAC
Sold after exercise
535
$90.00
$48.15K
BOBO DONALD E JR
12 Jun 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$87.54
$437.70K
Ullem Scott B.
21 May 2024
CVP, Chief Financial Officer
Sold after exercise
5,625
$90.45
$508.80K
BOBO DONALD E JR
10 May 2024
CVP,Strategy/Corp Development
Sold after exercise
5,000
$87.81
$439.04K
Lippis Daniel J.
7 May 2024
CVP, JAPAC
Sold after exercise
857
$85.60
$73.36K
MUSSALLEM MICHAEL A
2 May 2024
Director
Sold after exercise
17,143
$84.59
$1.45M
MUSSALLEM MICHAEL A
2 May 2024
Director
Sold after exercise
12,207
$85.02
$1.04M
Lemercier Jean-Luc M
1 May 2024
CVP, EMEACLA and JAPAC
Sold after exercise
12,240
$84.11
$1.03M
Lemercier Jean-Luc M
1 May 2024
CVP, EMEACLA and JAPAC
Sold after exercise
2,160
$84.83
$183.24K
Ullem Scott B.
30 Apr 2024
CVP, Chief Financial Officer
Sold after exercise
6,550
$85.74
$561.58K
Ullem Scott B.
30 Apr 2024
CVP, Chief Financial Officer
Sold after exercise
700
$86.40
$60.48K
Lippis Daniel J.
9 Apr 2024
CVP, JAPAC
Sold after exercise
857
$92.34
$79.14K
BOBO DONALD E JR
8 Apr 2024
CVP,Strategy/Corp Development
Sold after exercise
12,400
$92.33
$1.14M
BOBO DONALD E JR
8 Apr 2024
CVP,Strategy/Corp Development
Sold after exercise
100
$92.66
$9.27K
Lemercier Jean-Luc M
8 Apr 2024
CVP, EMEACLA
Sold after exercise
14,293
$92.32
$1.32M
Lemercier Jean-Luc M
8 Apr 2024
CVP, EMEACLA
Sold after exercise
107
$92.65
$9.91K
MUSSALLEM MICHAEL A
4 Apr 2024
Director
Sold after exercise
16,618
$92.70
$1.54M
MUSSALLEM MICHAEL A
4 Apr 2024
Director
Sold after exercise
9,820
$91.54
$898.92K
MUSSALLEM MICHAEL A
4 Apr 2024
Director
Sold after exercise
2,712
$93.72
$254.17K
MUSSALLEM MICHAEL A
4 Apr 2024
Director
Sold after exercise
200
$94.19
$18.84K
Ullem Scott B.
1 Apr 2024
CVP, Chief Financial Officer
Sold after exercise
6,387
$94.81
$605.52K
Ullem Scott B.
1 Apr 2024
CVP, Chief Financial Officer
Sold after exercise
868
$95.51
$82.90K
BOBO DONALD E JR
13 Mar 2024
CVP,Strategy/Corp Development
Sold after exercise
14,500
$91.01
$1.32M
Lemercier Jean-Luc M
11 Mar 2024
CVP, EMEACLA and JAPAC
Sold after exercise
14,400
$91.68
$1.32M
Lippis Daniel J.
7 Mar 2024
CVP, JAPAC
Sold after exercise
1,715
$90.98
$156.03K
MUSSALLEM MICHAEL A
4 Mar 2024
Director
Sold after exercise
16,040
$87.05
$1.40M
MUSSALLEM MICHAEL A
4 Mar 2024
Director
Sold after exercise
13,310
$86.21
$1.15M
Ullem Scott B.
29 Feb 2024
CVP, Chief Financial Officer
Sold after exercise
7,255
$85.59
$620.92K
GALLAHUE KIERAN
23 Feb 2024
Director
Sold after exercise indirect
3,058
$87.61
$267.91K
Chopra Daveen
21 Feb 2024
CVP, TMTT
Sold after exercise
7,000
$86.75
$607.27K
Chopra Daveen
21 Feb 2024
CVP, TMTT
Sold after exercise
1,200
$86.67
$104.00K
Szyman Catherine M.
15 Feb 2024
CVP, Critical Care
Sold after exercise
27,000
$85.62
$2.31M
BOBO DONALD E JR
13 Feb 2024
CVP,Strategy/Corp Development
Sold after exercise
10,530
$85.81
$903.57K
BOBO DONALD E JR
13 Feb 2024
CVP,Strategy/Corp Development
Sold after exercise
470
$86.35
$40.58K
Szyman Catherine M.
13 Feb 2024
CVP, Critical Care
Sold after exercise
20,000
$86.46
$1.73M
SELLERS ROBERT W.A.
12 Feb 2024
SVP, Corporate Controller
Sold after exercise
12,210
$87.00
$1.06M
STONE HEISZ LESLIE
8 Feb 2024
Director
Sold after exercise
7,056
$86.45
$609.99K
MUSSALLEM MICHAEL A
5 Feb 2024
Director
Sold after exercise
12,167
$87.55
$1.07M
MUSSALLEM MICHAEL A
5 Feb 2024
Director
Sold after exercise
9,761
$86.44
$843.74K
MUSSALLEM MICHAEL A
5 Feb 2024
Director
Sold after exercise
6,422
$88.63
$569.18K
MUSSALLEM MICHAEL A
5 Feb 2024
Director
Sold after exercise
1,000
$89.61
$89.61K
Ullem Scott B.
1 Feb 2024
CVP, Chief Financial Officer
Sold after exercise
7,255
$78.29
$567.99K
BOBO DONALD E JR
12 Jan 2024
CVP,Strategy/Corp Development
Sold after exercise
10,000
$75.67
$756.70K
MUSSALLEM MICHAEL A
5 Jan 2024
Director
Sold after exercise
26,850
$72.94
$1.96M
MUSSALLEM MICHAEL A
5 Jan 2024
Director
Sold after exercise
2,500
$73.46
$183.65K
Ullem Scott B.
29 Dec 2023
CVP, Chief Financial Officer
Sold after exercise
14,510
$76.55
$1.11M
Chopra Daveen
15 Dec 2023
CVP, TMTT
Sold after exercise
7,000
$78.25
$547.72K
MUSSALLEM MICHAEL A
13 Dec 2023
Director
Sold after exercise
13,722
$75.12
$1.03M
MUSSALLEM MICHAEL A
13 Dec 2023
Director
Sold after exercise
10,600
$74.22
$786.73K
MUSSALLEM MICHAEL A
13 Dec 2023
Director
Sold after exercise
3,200
$73.15
$234.08K
MUSSALLEM MICHAEL A
13 Dec 2023
Director
Sold after exercise
1,828
$75.73
$138.43K
Wood Larry L
13 Dec 2023
Global President TAVR & Surg
Sold after exercise
8,658
$71.86
$622.16K
BOBO DONALD E JR
13 Dec 2023
CVP,Strategy/Corp Development
Sold after exercise
8,000
$71.86
$574.88K
Chopra Daveen
6 Dec 2023
CVP, TMTT
Sold after exercise
3,500
$70.00
$245.01K
BOBO DONALD E JR
13 Nov 2023
CVP,Strategy/Corp Development
Sold after exercise
3,700
$65.66
$242.93K
BOBO DONALD E JR
13 Nov 2023
CVP,Strategy/Corp Development
Sold after exercise
2,300
$64.72
$148.85K
Wood Larry L
13 Nov 2023
Global President TAVR & Surg
Sold after exercise
5,402
$65.64
$354.57K
Wood Larry L
13 Nov 2023
Global President TAVR & Surg
Sold after exercise
3,158
$64.68
$204.27K
Wood Larry L
13 Nov 2023
Global President TAVR & Surg
Sold after exercise
100
$66.21
$6.62K
MUSSALLEM MICHAEL A
3 Nov 2023
Director
Sold after exercise
29,350
$67.18
$1.97M
Ullem Scott B.
31 Oct 2023
CVP, Chief Financial Officer
Sold after exercise
7,255
$62.66
$454.57K
BOBO DONALD E JR
13 Oct 2023
CVP,Strategy/Corp Development
Sold after exercise
3,000
$70.25
$210.75K
BOBO DONALD E JR
13 Oct 2023
CVP,Strategy/Corp Development
Sold after exercise
2,000
$69.58
$139.16K
Wood Larry L
13 Oct 2023
Global President TAVR & Surg
Sold after exercise
5,150
$70.26
$361.86K
Wood Larry L
13 Oct 2023
Global President TAVR & Surg
Sold after exercise
3,510
$69.61
$244.33K
Szyman Catherine M.
10 Oct 2023
CVP, Critical Care
Sold after exercise
5,000
$72.68
$363.40K
Chopra Daveen
3 Oct 2023
CVP, TMTT
Sold after exercise
8,500
$70.00
$595.00K
MUSSALLEM MICHAEL A
2 Oct 2023
Director
Sold after exercise
29,350
$68.84
$2.02M
Ullem Scott B.
29 Sep 2023
CVP, Chief Financial Officer
Sold after exercise
7,255
$69.54
$504.53K
Wood Larry L
14 Sep 2023
Global President TAVR & Surg
Sold after exercise
8,660
$73.63
$637.62K
BOBO DONALD E JR
14 Sep 2023
CVP,Strategy/Corp Development
Sold after exercise
4,500
$73.71
$331.70K
Szyman Catherine M.
8 Sep 2023
CVP, Critical Care
Sold after exercise
5,000
$76.00
$380.00K
Chopra Daveen
6 Sep 2023
CVP, TMTT
Sold after exercise
8,500
$76.07
$646.61K
MUSSALLEM MICHAEL A
5 Sep 2023
Director
Sold after exercise
29,350
$75.86
$2.23M
Ullem Scott B.
31 Aug 2023
CVP, Chief Financial Officer
Sold after exercise
7,255
$77.79
$564.37K
Wood Larry L
14 Aug 2023
Global President TAVR & Surg
Sold after exercise
6,421
$79.30
$509.19K
BOBO DONALD E JR
14 Aug 2023
CVP,Strategy/Corp Development
Sold after exercise
4,500
$79.30
$356.85K
Szyman Catherine M.
9 Aug 2023
CVP, Critical Care
Sold after exercise
5,000
$78.64
$393.19K
MUSSALLEM MICHAEL A
7 Aug 2023
Director
Sold after exercise
29,050
$79.86
$2.32M
MUSSALLEM MICHAEL A
7 Aug 2023
Director
Sold after exercise
300
$80.54
$24.16K
Ullem Scott B.
31 Jul 2023
CVP, Chief Financial Officer
Sold after exercise
7,255
$84.35
$611.96K
Wood Larry L
14 Jul 2023
Global President TAVR & Surg
Sold after exercise
8,660
$92.94
$804.84K
BOBO DONALD E JR
14 Jul 2023
CVP,Strategy/Corp Development
Sold after exercise
3,500
$92.94
$325.28K
Szyman Catherine M.
10 Jul 2023
CVP, Critical Care
Sold after exercise
5,000
$90.52
$452.60K
MUSSALLEM MICHAEL A
5 Jul 2023
Director
Sold after exercise
21,728
$90.63
$1.97M
MUSSALLEM MICHAEL A
5 Jul 2023
Director
Sold after exercise
7,622
$91.22
$695.28K
Ullem Scott B.
30 Jun 2023
CVP, Chief Financial Officer
Sold after exercise
7,255
$93.27
$676.67K
Wood Larry L
14 Jun 2023
Global President TAVR & Surg
Sold after exercise
5,810
$89.87
$522.15K
Wood Larry L
14 Jun 2023
Global President TAVR & Surg
Sold after exercise
2,850
$90.71
$258.53K
BOBO DONALD E JR
14 Jun 2023
CVP,Strategy/Corp Development
Sold after exercise
3,500
$89.77
$314.20K
Szyman Catherine M.
13 Jun 2023
CVP, Critical Care
Sold after exercise
5,000
$85.81
$429.05K
MUSSALLEM MICHAEL A
1 Jun 2023
Director
Sold after exercise
18,654
$84.57
$1.58M
MUSSALLEM MICHAEL A
1 Jun 2023
Director
Sold after exercise
5,396
$85.08
$459.09K
MUSSALLEM MICHAEL A
1 Jun 2023
Director
Sold after exercise
5,300
$83.43
$442.18K
Wood Larry L
24 May 2023
Global President TAVR & Surg
Sold after exercise
6,421
$84.23
$540.84K
MUSSALLEM MICHAEL A
10 May 2023
Chairman & CEO
Sold after exercise
13,891
$88.29
$1.23M
MUSSALLEM MICHAEL A
10 May 2023
Chairman & CEO
Sold after exercise
5,984
$88.94
$532.22K
Ullem Scott B.
10 May 2023
CVP, Chief Financial Officer
Sold after exercise
64,119
$88.36
$5.67M
Ullem Scott B.
10 May 2023
CVP, Chief Financial Officer
Sold after exercise
16,581
$89.22
$1.48M
BOBO DONALD E JR
10 May 2023
CVP,Strategy/Corp Development
Sold after exercise
2,500
$89.22
$223.05K
Szyman Catherine M.
9 May 2023
CVP, Critical Care
Sold after exercise
75,600
$88.94
$6.72M
Lemercier Jean-Luc M
9 May 2023
CVP, EMEACLA and JAPAC
Sold after exercise
6,640
$88.68
$588.84K
SELLERS ROBERT W.A.
28 Apr 2023
SVP, Corporate Controller
Sold after exercise
12,270
$87.20
$1.07M
MUSSALLEM MICHAEL A
14 Apr 2023
Chairman & CEO
Sold after exercise
16,059
$84.10
$1.35M
MUSSALLEM MICHAEL A
14 Apr 2023
Chairman & CEO
Sold after exercise
3,816
$84.61
$322.87K
Lemercier Jean-Luc M
6 Apr 2023
CVP, EMEACLA and JAPAC
Sold after exercise
6,640
$83.10
$551.77K
BOBO DONALD E JR
6 Apr 2023
CVP,Strategy/Corp Development
Sold after exercise
6,725
$83.09
$558.80K
Chopra Daveen
15 Mar 2023
CVP, TMTT
Sold after exercise
4,435
$77.47
$343.56K
MUSSALLEM MICHAEL A
14 Mar 2023
Chairman & CEO
Sold after exercise
10,700
$77.86
$833.10K
MUSSALLEM MICHAEL A
14 Mar 2023
Chairman & CEO
Sold after exercise
9,175
$77.32
$709.41K
BOBO DONALD E JR
8 Mar 2023
CVP,Strategy/Corp Development
Sold after exercise
6,725
$76.96
$517.56K
Lemercier Jean-Luc M
8 Mar 2023
CVP, EMEACLA and JAPAC
Sold after exercise
6,590
$76.95
$507.12K
Lemercier Jean-Luc M
8 Mar 2023
CVP, EMEACLA and JAPAC
Sold after exercise
50
$77.43
$3.87K
STONE HEISZ LESLIE
16 Feb 2023
Director
Sold after exercise
9,671
$76.82
$742.94K
Chopra Daveen
15 Feb 2023
CVP, TMTT
Sold after exercise
4,000
$76.01
$304.04K
MUSSALLEM MICHAEL A
14 Feb 2023
Chairman & CEO
Sold after exercise
16,275
$76.83
$1.25M
MUSSALLEM MICHAEL A
14 Feb 2023
Chairman & CEO
Sold after exercise
3,600
$77.75
$279.90K
BOBO DONALD E JR
6 Feb 2023
CVP,Strategy/Corp Development
Sold after exercise
6,725
$80.75
$543.04K
Chopra Daveen
17 Jan 2023
CVP, TMTT
Sold after exercise
4,000
$78.00
$312.00K
MUSSALLEM MICHAEL A
13 Jan 2023
Chairman & CEO
Sold after exercise
19,875
$78.09
$1.55M
BOBO DONALD E JR
9 Jan 2023
CVP,Strategy/Corp Development
Sold after exercise
6,725
$77.50
$521.19K
Chopra Daveen
15 Dec 2022
CVP, Surgical Structural Heart
Sold after exercise
4,000
$74.80
$299.20K
MUSSALLEM MICHAEL A
14 Dec 2022
Chairman & CEO
Sold after exercise
12,155
$76.04
$924.27K
MUSSALLEM MICHAEL A
14 Dec 2022
Chairman & CEO
Sold after exercise
7,420
$76.93
$570.82K
MUSSALLEM MICHAEL A
14 Dec 2022
Chairman & CEO
Sold after exercise
300
$77.51
$23.25K
Wood Larry L
13 Dec 2022
CVP, TAVR
Sold after exercise
6,936
$76.96
$533.77K
Wood Larry L
13 Dec 2022
CVP, TAVR
Sold after exercise
300
$77.48
$23.24K
BOBO DONALD E JR
12 Dec 2022
CVP,Strategy/Corp Development
Sold after exercise
6,725
$74.32
$499.80K
Chopra Daveen
15 Nov 2022
CVP, Surgical Structural Heart
Sold after exercise
4,000
$74.18
$296.72K
MUSSALLEM MICHAEL A
14 Nov 2022
Chairman & CEO
Sold after exercise
15,575
$73.94
$1.15M
MUSSALLEM MICHAEL A
14 Nov 2022
Chairman & CEO
Sold after exercise
4,100
$74.86
$306.93K
MUSSALLEM MICHAEL A
14 Nov 2022
Chairman & CEO
Sold after exercise
200
$75.47
$15.09K
Wood Larry L
8 Nov 2022
CVP, TAVR
Sold after exercise
7,242
$68.50
$496.06K
BOBO DONALD E JR
8 Nov 2022
CVP,Strategy/Corp Development
Sold after exercise
6,725
$68.46
$460.39K
Chopra Daveen
14 Oct 2022
CVP, Surgical Structural Heart
Sold after exercise
4,000
$84.77
$339.08K
MUSSALLEM MICHAEL A
14 Oct 2022
Chairman & CEO
Sold after exercise
14,497
$82.41
$1.19M
MUSSALLEM MICHAEL A
14 Oct 2022
Chairman & CEO
Sold after exercise
2,978
$83.38
$248.31K
MUSSALLEM MICHAEL A
14 Oct 2022
Chairman & CEO
Sold after exercise
1,800
$84.64
$152.35K
MUSSALLEM MICHAEL A
14 Oct 2022
Chairman & CEO
Sold after exercise
600
$85.28
$51.17K
Wood Larry L
11 Oct 2022
CVP, TAVR
Sold after exercise
7,242
$82.12
$594.71K
BOBO DONALD E JR
10 Oct 2022
CVP,Strategy/Corp Development
Sold after exercise
6,725
$85.00
$571.63K
MUSSALLEM MICHAEL A
22 Sep 2022
Chairman & CEO
Sold after exercise
16,675
$84.07
$1.40M
MUSSALLEM MICHAEL A
22 Sep 2022
Chairman & CEO
Sold after exercise
3,100
$84.66
$262.45K
MUSSALLEM MICHAEL A
22 Sep 2022
Chairman & CEO
Sold after exercise
100
$85.26
$8.53K
BOBO DONALD E JR
8 Sep 2022
CVP,Strategy/Corp Development
Sold after exercise
6,725
$90.94
$611.57K
Wood Larry L
6 Sep 2022
CVP, TAVR
Sold after exercise
7,242
$89.00
$644.54K
MUSSALLEM MICHAEL A
15 Aug 2022
Chairman & CEO
Sold after exercise
15,773
$104.92
$1.65M
MUSSALLEM MICHAEL A
15 Aug 2022
Chairman & CEO
Sold after exercise
4,002
$104.03
$416.33K
Showing 250 of 981 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 919
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 859
Sales at will 104
Transactions with no price 0
Shares from compensation/vesting 13,268,825
Sales filed before the plan box existed 77
History held since 29 Aug 2016